K Number
K112109
Date Cleared
2011-12-22

(153 days)

Product Code
Regulation Number
892.2050
Reference & Predicate Devices
Predicate For
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
Intended Use

The KINEGRAPH VMA™ software is a quantitative imaging software application intended to be used to process digital image files. It is designed for physicians and clinical professionals who are interested in the analysis of motion in medical images, particularly in musculoskeletal images of the spine. KINEGRAPH VMA™ software permits users to review static and dynamic digital lumbar spine images acquired with the assistance of the MOTION NORMALIZER™ patient handling and data collection device, which is designed for use by imaging technicians and intended to assist with patient lumbar bending and data collection during imaging. KINEGRAPH VMA™ software also facilitates quantitative assessment of vertebral motion in digital medical images. Information about the motion of selected objects, such as bone structures, can be generated and presented in the form of a 'motion analysis' report containing graphics, charts, and text.

Device Description

The subject device consists of the KINEGRAPH VMA™ software that analyzes images from the MOTION NORMALIZER™ on an Off-the-Shelf ("OTS") imaging workstation. The MOTION NORMALIZER patient handling and data collection device is an accessory device to the KINEGRAPH VMA™ software that is used to assist with subject lumbar bending and data collection while images are captured with standard fluoroscopes. The MOTION NORMALIZER is comprised of two powered, electromechanical patient handling devices connected to and controlled by a consolemounted OTS computer running custom software connected to various OTS hardware accessories. The subject system is able to capture and record fluoroscopic image data, as well as data from the patient handling devices, and to output this data into DICOM compatible digital image files for analysis using the KINEGRAPH VMA™ software.

AI/ML Overview

The provided document, K112109, does not contain the specific detailed acceptance criteria or a study that rigorously proves the device meets such criteria with quantitative performance metrics for a medical imaging AI device as typically understood today. The information available is very high-level and predates the common expectations for AI/ML device submissions.

However, based on the available text, here's an attempt to structure the information as requested, highlighting what is present and what is conspicuously absent:

Acceptance Criteria and Study for KINEGRAPH VMA™ Software and MOTION NORMALIZER™

1. Table of Acceptance Criteria and Reported Device Performance

Acceptance Criteria CategorySpecific Criteria (Implicit/General)Reported Device Performance (Implicit/General)
FunctionalityDevice functions as intended."functioned as intended" (General Statement)
Validation & VerificationCompliance with FDA regulations and recognized standards for validation and verification.Designed and developed in accordance with FDA regulations, including validation and verification testing per FDA recognized standards.
RepeatabilityDevice produces consistent results under repeated conditions.Repeatability testing was performed. (No specific thresholds or quantitative results are provided).
AccuracyDevice produces results that are close to the true value (though "true value" is not defined here).Accuracy testing was performed. (No specific thresholds or quantitative results are provided).
Substantial EquivalenceSame intended use, indications for use, technological characteristics, and principles of operation as predicate devices, with no new issues of safety or effectiveness.The device has the same intended use, indications for use, technological characteristics, and principles of operation as identified predicate devices. Validation and verification data demonstrate the subject device functions as intended and performs functions substantially equivalent to the predicate devices.

Missing Information: Crucially, the document does not provide quantitative acceptance criteria (e.g., minimum sensitivity, specificity, accuracy thresholds, or specific error margins for motion analysis), nor does it present quantitative performance results against such criteria. The statements are largely qualitative assertions.


2. Sample Size Used for the Test Set and Data Provenance

  • Sample Size for Test Set: Not specified. The document states "repeatability and accuracy testing was performed" but does not give any details on the number of cases or subjects used for this testing.
  • Data Provenance: Not specified. There is no information provided regarding the country of origin of the data, nor whether it was retrospective or prospective.

3. Number of Experts Used to Establish Ground Truth for the Test Set and Qualifications of Those Experts

  • Number of Experts: Not specified.
  • Qualifications of Experts: Not specified.
  • Role of Experts: The document does not indicate if experts were used to establish ground truth in the context of performance testing. The KINEGRAPH VMA™ software is an analytical tool for "physicians and clinical professionals," implying their use of the output rather than their role in ground truth establishment for validation.

4. Adjudication Method for the Test Set

  • Adjudication Method: Not specified, and likely not applicable in the context described, as ground truth establishment by experts for specific performance metrics is not detailed.

5. Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study

  • MRMC Study Done: No, there is no mention of a Multi-Reader Multi-Case (MRMC) comparative effectiveness study being performed. The document describes the device as a software for quantitative analysis and data collection, not a tool for human reader interpretation improvement, which would be the typical context for an MRMC study.
  • Effect Size: Not applicable, as no MRMC study was performed or reported.

6. Standalone (Algorithm Only Without Human-in-the-Loop) Performance Study

  • Standalone Study Done: Yes, in a general sense. The "repeatability and accuracy testing" refers to the performance of the KINEGRAPH VMA™ software and its accessory. The software's function is to "facilitate quantitative assessment of vertebral motion" and generate reports. While a human uses the output, the testing described would be of the algorithm's ability to process images and generate these quantitative assessments. However, the exact methods and quantitative results of this standalone performance are not provided.

7. Type of Ground Truth Used

  • Type of Ground Truth: Not explicitly stated. For "accuracy testing," it would imply comparison against a known "true" value. Given the system's function (analysis of motion in musculoskeletal images of the spine), potential ground truth could involve:
    • Phantom studies: Using precisely controlled physical models with known motion characteristics.
    • Manual measurements: Highly precise manual measurements by experts on the same images, though the document doesn't specify this.
    • Clinical correlation/Pathology: Unlikely to be the direct ground truth for motion analysis in this context, but perhaps for clinical utility validation.
      The document only broadly states "accuracy testing was performed," but does not detail how accuracy was determined against a ground truth.

8. Sample Size for the Training Set

  • Sample Size for Training Set: Not applicable / Not specified. The KINEGRAPH VMA™ software, from the description, appears to be a rule-based or algorithmic system for quantitative measurement and image processing, rather than an AI/ML system that would require a dedicated training set in the modern sense. There is no mention of machine learning or deep learning, which would necessitate a training set. The term "software" is used, implying traditional programming.

9. How the Ground Truth for the Training Set Was Established

  • Ground Truth for Training Set: Not applicable, as there is no indication of a training set for an AI/ML model.

{0}------------------------------------------------

K112109

510(k) SUMMARY

DEC 2 2 2011

ORTHO KINEMATICS, INC.

INTEGRAL SYSTEM COMPRISED OF THE KINEGRAPH VMA™ (VERTEBRAL MOTION ANALYZER) SOFTWARE AND ITS ACCESSORY DEVICE, THE MOTION NORMALIZER IMAGE™ PATIENT HANDLING AND DATA COLLECTION DEVICE

SUBMITTED BYOrtho Kinematics, Inc.7004 Bee Caves Rd.,Bldg. 3, Ste. 315Austin, Texas 78746
---------------------------------------------------------------------------------------------------------
CONTACT PERSONPrimary:Adam DeitzCEOOrtho KinematicsPhone: (415) 699-1736Fax: (512) 334-5500Alternate:Brian J. BergeronEngineeringOrtho KinematicsPhone: (508) 735-1590Fax: (512) 382-6372
DATE PREPAREDDecember 2, 2011
CLASSIFICATION NAME /PRODUCT CODESystem, Image Processing, Radiological / LLZ
DEVICE CLASSClass II
REGULATION NUMBER21 C.F.R. 892.2050
PROPRIETARY NAMEThe integral system comprised of:- the KINEGRAPH VMA™ (VERTEBRAL MOTIONANALYZER) software, and its accessory device,- the MOTION NORMALIZER™ patient handling and

PREDICATE DEVICE

Medical Metrics, Inc.'s KIMAX QMA Radiological Image Processing System (K022585) Villa Sistemi Medicali, spa's Apollo (K050190) Steris Corporation's Steris 5085 SRT (K090136)

data collection device

INTENDED USE / INDICATIONS FOR USE

The KINEGRAPH VMA™ software is a quantitative imaging software application intended to be used to process digital image files. It is designed for physicians and

{1}------------------------------------------------

clinical professionals who are interested in the analysis of motion in medical images, particularly in musculoskeletal images of the spine. KINEGRAPH VMA™ software permits users to review static and dynamic digital lumbar spine images acquired with the assistance of the MOTION NORMALIZER™ patient handling and data collection device, which is designed for use by imaging technicians and intended to assist with patient lumbar bending and data collection during imaging. KINEGRAPH VMA™ software also facilitates quantitative assessment of vertebral motion in digital medical images. Information about the motion of selected objects, such as bone structures, can be generated and presented in the form of a 'motion analysis' report containing graphics. charts, and text.

TECHNOLOGICAL CHARACTERISTICS / PRINCIPLES OF OPERATION

The subject device consists of the KINEGRAPH VMA™ software that analyzes images from the MOTION NORMALIZER™ on an Off-the-Shelf ("OTS") imaging workstation. The MOTION NORMALIZER patient handling and data collection device is an accessory device to the KINEGRAPH VMA™ software that is used to assist with subject lumbar bending and data collection while images are captured with standard fluoroscopes. The MOTION NORMALIZER is comprised of two powered, electromechanical patient handling devices connected to and controlled by a consolemounted OTS computer running custom software connected to various OTS hardware accessories. The subject system is able to capture and record fluoroscopic image data, as well as data from the patient handling devices, and to output this data into DICOM compatible digital image files for analysis using the KINEGRAPH VMA™ software.

PERFORMANCE DATA

The KINEGRAPH VMA™ software and its accessory device, the MOTION NORMALIZER™, have been designed and developed in accordance with FDA regulations, including validation and verification testing per FDA recognized standards. In addition, repeatability and accuracy testing was performed for the integral system. In all instances, the KINEGRAPH VMA™ software and its accessory device, the MOTION NORMALIZER™, functioned as intended.

SUBSTANTIAL EQUIVALENCE

The KINEGRAPH VMA™ software and its accessory device, the MOTION NORMALIZER™, has the same intended use and indications for use, technological characteristics, and principles of operation as the identified predicate devices. The minor technological differences between the KINEGRAPH VMA™ software and its accessory device, the MOTION NORMALIZER™, and the predicate devices raise no new issues of safety or effectiveness. Validation and verification data (including software validation) demonstrate that the subject device functions as intended, and performs functions substantially equivalent to the predicate devices.

{2}------------------------------------------------

Image /page/2/Picture/0 description: The image shows the logo for the Department of Health & Human Services (HHS). The logo features the department's name encircling a stylized eagle emblem. The text reads "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" in a circular arrangement. The eagle emblem is composed of three curved lines, representing the department's mission to protect the health of all Americans and provide essential human services.

DEPARTMENT OF HEALTH & HUMAN SERVICES

Public Health Service

Food and Drug Administration 10903 New Hampshire Avenue Document Control Room - WO66-G609 Silver Spring, MD 20993-0002

Ortho Kinematics, Inc. % Mr. John J. Smith. M.D., J.D. Regulatory Counsel Hogan Lovells US LLP 555 13th Street, NW WASHINGTON DC, 20004

DEC 2 2 2011

Re: K112109

Trade/Device Name: KINEGRAPH VMA™ (VERTEBRAL MOTION ANALYZER) software and its accessory, the MOTION NORMALIZER™ patient handling and data collection device Regulation Number: 21 CFR 892.2050 Regulation Name: Picture archiving and communications system Regulatory Class: II Product Code: LLZ Dated: December 5th, 2011 Received: December 50, 2011

Dear Dr. Smith:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into class II (Special Controls), it may be subject to such additional controls. Existing major regulations affecting your device can be found in Title 21, Code of Federal Regulations (CFR), Parts 800 to 895. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807): labeling (21 CFR Parts 801 and 809); medical device reporting (reporting of

{3}------------------------------------------------

medical device-related adverse events) (21 CFR 803); and good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820). This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed nouticate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Parts 801 and 809), please contact the Office of In Vitro Diagnostic Device Evaluation and Safety at (301) 796-5450. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.

Sincerely Yours.

Mary Pastel

Mary S. Pastel, Sc.D. Director Division of Radiological Devices Office of In Vitro Diagnostic Device Evaluation and Safety Center for Devices and Radiological Health

Enclosure

{4}------------------------------------------------

Indications for Use

510(k) Number (if known): K112109

Device Name: KINEGRAPH VMA™ (VERTEBRAL MOTION ANALYZER) software and its accessory, the MOTION NORMALIZER™ patient handling and data collection device

Indications for Use:

The KINEGRAPH VMA™ software is a quantitative imaging software application intended to be used to process digital image files. It is designed for physicians and clinical professionals who are interested in the analysis of motion in medical images, particularly in musculoskeletal images of the spine. KINEGRAPH VMA™ software permits users to review static and dynamic digital lumbar spine images acquired with the assistance of the MOTION NORMALIZER™ patient handling and data collection device, which is designed for use by imaging technicians and intended to assist with patient lumbar bending and data collection during imaging. KINEGRAPH VMA™ software also facilitates quantitative assessment of vertebral motion in digital medical images. Information about the motion of selected objects, such as bone structures, can be generated and presented in the form of a 'motion analysis' report containing graphics, charts, and text.

Prescription Use X (Part 21 CFR 801 Subpart D)

AND/OR

Over-The-Counter Use (21 CFR 807 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of In Vitro Diagnostic Devices (OIVD)
(Division Sign-Off)
Division of Radiological Devices
Office of In Vitro Diagnostic Device Evaluation and Safety
210/1-\
Annual of control condition-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Page I of 1

§ 892.2050 Medical image management and processing system.

(a)
Identification. A medical image management and processing system is a device that provides one or more capabilities relating to the review and digital processing of medical images for the purposes of interpretation by a trained practitioner of disease detection, diagnosis, or patient management. The software components may provide advanced or complex image processing functions for image manipulation, enhancement, or quantification that are intended for use in the interpretation and analysis of medical images. Advanced image manipulation functions may include image segmentation, multimodality image registration, or 3D visualization. Complex quantitative functions may include semi-automated measurements or time-series measurements.(b)
Classification. Class II (special controls; voluntary standards—Digital Imaging and Communications in Medicine (DICOM) Std., Joint Photographic Experts Group (JPEG) Std., Society of Motion Picture and Television Engineers (SMPTE) Test Pattern).